ATTAIN Clinical Trial Data What the Evidence Shows Orforgliprons FDA approval was based on the ATTAIN Phase 3 clinical development program, which enrolled more than 4,500 participants across two major registration trials
Treatment is usually continued as long as it remains effective, well tolerated, and accessible
In 1 day Provider writes a prescription Within 1 day Order ships from our US-Certified pharmacies Free & Discreet 2-day shipping Get your medication On-going patient support Start your treatment 98% Sunlight patient success rate 2+ Sunlight patients drop 2 or more clothing sizes 20lbs Average weight loss in the first 3 months 9/10 Sunlight patients kept it off for good Whats included with the Sunlight weight loss program
Misunderstanding the results can lead to unnecessary anxiety, inappropriate interventions, or a false sense of security
In contrast, Ozempic and Wegovy primarily work by dulling appetite, with less emphasis on broader metabolic resilience
Lm sch mt